- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Pediatric Surgery in Oncology: Innovations, Challenges, and Future Directions
Deadline: 30 September 2026
Current Status of Neuroendocrine Tumors with a Special Focus on Diagnosis and Novel Treatments—3rd Edition
Deadline: 30 September 2026
Extracellular Matrix Proteins in Cancer (2nd Edition)
Deadline: 30 September 2026
CRLM in the Era of Transplant Oncology: New Hope, New Questions
Deadline: 30 September 2026
Advances in Clinical Pharmacology in Lung Cancer—2nd Edition
Deadline: 30 September 2026
Recent Advances in Myeloma: From Molecular Pathways to Drug Development
Deadline: 30 September 2026
Pre-Clinical Studies of Personalized Medicine for Cancer Research: 2nd Edition
Deadline: 30 September 2026
Advances in Clinical Trials and Precision Medicine for Neuro-Oncology
Deadline: 30 September 2026
Advances in Brain Tumors
Deadline: 30 September 2026
New Clinical Insights into Gynecological Malignancies
Deadline: 30 September 2026
The Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion (Third Edition)
Deadline: 30 September 2026
Translational Advances in Reproductive Cancers: From Targets to Therapies
Deadline: 30 September 2026
of 261

